TITLE

Genome Discoveries Shape Drug Development and Testing

AUTHOR(S)
Wechsler, Jill
PUB. DATE
June 2003
SOURCE
Applied Clinical Trials;Jun2003, Vol. 12 Issue 6, p22
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Explores genomic discoveries and their implications for drug development and testing. Development of genome-based approaches to predicting disease susceptibility and drug response; Technological advances that would reduce the cost of genotyping; Analysis of gene expression in circulating leukocytes; Proteomic analysis of body fluids; Implications for the early detection of disease. INSET: Turning Genomics Vision into Reality.
ACCESSION #
9990018

 

Related Articles

  • Drug Target Mining and Analysis of the Chinese Tree Shrew for Pharmacological Testing. Zhao, Feng; Guo, Xiaolong; Wang, Yanjie; Liu, Jie; Lee, Wen-hui; Zhang, Yun // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    The discovery of new drugs requires the development of improved animal models for drug testing. The Chinese tree shrew is considered to be a realistic candidate model. To assess the potential of the Chinese tree shrew for pharmacological testing, we performed drug target prediction and analysis...

  • Harmonizing Standards and Specifications.  // Pharmaceutical Technology Europe;May2002, Vol. 14 Issue 5, p17 

    Focuses on product specifications during drug development and the corresponding standards imposed by the U.S. Food and Drug Administration. Initial drug specification testing; Discussion on the shelf-life of pharmaceutical product; Dissolution and disintegration test of drugs. INSET: ICH update.

  • Improving Dose Content Uniformity Testing for MDIs and DPIs. Tuckwell, Jon; Sewell, Roger // Pharmaceutical Technology Europe;Jan2003, Vol. 15 Issue 1, p39 

    Discusses a drug content uniformity test that allows the quality of a batch of drug product to be determined accurately, using a suitable number of samples for the quality of the batch. Application of the Bayesian Inference to the test's development; Comparison with the test used by the U.S....

  • Leishmania amastigotes as targets for drug screening. Monte-Alegre, Adriano; Ouaissi, Ali; Sereno, Denis // Kinetoplastid Biology & Disease;2006, Vol. 5, p1 

    Direct drug screening against the mammalian stage of Leishmania has been hampered by cost and the time consuming effort required to accomplish it. The ability to derive transgenic Leishmania expressing reporter genes opened up new possibilities for the development of drug screening tests....

  • Scientists develop a 'vaccine' against diabetes. Siegel-Itzkovich, Judy // BMJ: British Medical Journal (International Edition);12/1/2001, Vol. 323 Issue 7324, p1272 

    Reports on the development of a drug, called DiaPep277 which could prevent type I diabetes. How the drug halts the immune system's destruction of pancreatic beta cells; Indication that the drug can halt the progression of the disease; Details of research conducted by Hadassah University...

  • A holistic view of GPCR signaling. Kenakin, Terry // Nature Biotechnology;Sep2010, Vol. 28 Issue 9, p928 

    The article focuses on the results of a study on the effectiveness of dynamic mass redistribution assays in capturing G protein-coupled receptor (GPCR) signaling compared with traditional assays conducted by R. Schröder and colleagues. The researchers stressed the significance of the assays...

  • High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery. Yang, Xiaonan; Kui, Ling; Tang, Min; Li, Dawei; Wei, Kunhua; Chen, Wei; Miao, Jianhua; Dong, Yang // Frontiers in Genetics;2/5/2020, p1 

    The development of new drugs is multidisciplinary and systematic work. High-throughput techniques based on "-omics" have driven the discovery of biomarkers in diseases and therapeutic targets of drugs. A transcriptome is the complete set of all RNAs transcribed by certain tissues or cells at a...

  • High-content screening: getting more from less. McCoy, jR., J. Philip // Nature Methods;May2011, Vol. 8 Issue 5, p390 

    The author comments on an article by Daniel Ehrlich and colleagues published within this issue of the periodical on the efficacy of high-content screening (HCS) analysis for drug discovery. It is stated that, HCS technique uses automated analysis of cell images to facilitate drug discovery and...

  • Mergers Reshape the Drug-Trial Industry. Gaudio, Thomas // njbiz;12/18/2006, Vol. 19 Issue 51, p3 

    The article focuses on the impact of the consolidation deals by some firms known as contract research organizations (CRO), on the drug-trial industry. ClinPhone, which made a deal with Datalabs, has allowed health care professionals managing a clinical study to enter their findings through a Web...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics